Ledger.Open graph →
SEC Form D · Amendment · filed March 11, 2010

NIIKI PHARMA INC

Offering
$5.0M
Sold
$3.8M
Exemption
Industry
Biotechnology
Location
HOBOKEN, NJ
Type

People & firms on this filing (4)

Ali Ardakani · Hoboken, NJExec · DirectorHooshmand Sheshbaradaran · Hoboken, NJExec · DirectorJeffrey S. Podell · Miami, FLExec · DirectorRichard J. Rosenstock · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗